FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, particularly to ophthalmology. An agent for promotion of corneal endotheliocyte adhesion containing an Rho kinase inhibitor, a culture medium for corneal endotheliocytes containing the Rho kinase inhibitor, a solution of cornea preservation containing the Rho kinase inhibitor, and a method for making a preparation of corneal endothelium involving the stage of corneal endotheliocyte culture with the use of the above culture medium.
EFFECT: group of inventions provides an ability for effective growing of corneal endotheliocytes and stable delivery of the preparation of corneal endothelium.
43 cl, 17 dwg, 19 ex
Title | Year | Author | Number |
---|---|---|---|
NEW CORNEAL TREATMENT WITH LAMININ | 2015 |
|
RU2718062C2 |
USING LAMININ IN CORNEAL ENDOTHELIAL CELL CULTURE | 2014 |
|
RU2704984C1 |
THERAPEUTIC AGENT (Y-39983) FOR CORNEAL ENDOTHELIAL DYSFUNCTION | 2010 |
|
RU2563141C2 |
THERAPEUTIC DRUG FOR DISEASES RELATED TO ENDOPLASMIC RETICULUM CELL DEATH IN CORNEAL ENDOTHELIUM | 2014 |
|
RU2712967C2 |
METHODS, SURFACE-MODIFIED CARRIERS AND COMPOSITIONS FOR IMMOBILISATION, CULTIVATION AND CELL DETACHMENT | 2009 |
|
RU2551772C2 |
THERAPEUTIC AGENTS DIRECTED TO THE ECM OF THE CORNEAL ENDOTHELIA | 2019 |
|
RU2800931C2 |
METHOD FOR PREPARING PANCREATIC HORMONE-PRODUCING CELLS | 2011 |
|
RU2576000C2 |
METHODS AND COMPOSITIONS FOR CELL FIXATION AND CULTURE ON FLAT CARRIERS | 2009 |
|
RU2547925C2 |
METHOD FOR PLURIPOTENT STEM CELLS DIFFERENTIATION INTO VASCULAR BED CELLS | 2012 |
|
RU2618871C2 |
CELL COMPOSITIONS DERIVED FROM DEDIFFERENTIATED REPROGRAMMED CELLS | 2014 |
|
RU2675928C2 |
Authors
Dates
2013-02-10—Published
2008-08-28—Filed